Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine

Infection and Immunity

Volumn 79, Issue 3, 2011, Pages 1311-1318

  Agnes, Joseph T ^a   Brayton, Kelly A ^a   LaFollett, Megan ^a   Norimine, Junzo ^a   Brown, Wendy C ^a   Palmer, Guy H ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASMA MARGINALE CENTRALE VACCINE; BACTERIAL ANTIGEN; BACTERIAL VACCINE; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANAPLASMA MARGINALE; ANAPLASMA MARGINALE CENTRALE; ANAPLASMOSIS; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; DRUG EFFICACY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANAPLASMA CENTRALE; ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BASE SEQUENCE; CATTLE; CHROMATOGRAPHY, LIQUID; CONSERVED SEQUENCE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; TANDEM MASS SPECTROMETRY;

EID: 79952287531     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01174-10     Document Type: Article

References (44)

1. Abbott, J. R., G. H. Palmer, C. J. Howard, J. C. Hope, and W. C. Brown. 2004. Anaplasma marginale major surface protein 2 CD4+ T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR. Infect. Immun. 72:7360-7366.
2. Barbet, A. F., A. Lundgren, J. Yi, F. R. Rurangirwa, and G. H. Palmer. 2000. Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics. Infect. Immun. 68:6133-6138.
3. Bock, R., and A. De Vos. 2001. Immunity following use of Australian tick fever vaccine: a review of the evidence. Aust. Vet. J. 79:832-839.
4. Brayton, K. A., et al. 2005. Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 102:844-849.
5. Brayton, K. A., G. H. Palmer, A. Lundgren, J. Yi, and A. F. Barbet. 2002. Antigenic variation of Anaplasma marginale msp2 occurs by combinatorial gene conversion. Mol. Microbiol. 43:1151-1159.
6. Brayton, K. A., D. P. Knowles, T. C. McGuire, and G. H. Palmer. 2001. Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens. Proc. Natl. Acad. Sci. U. S. A. 98:4130-4135.
7. Brayton, K. A., P. F. M. Meeus, A. F. Barbet, and G. H. Palmer. 2003. Simultaneous variation of the immunodominant outer membrane proteins, Msp2 and Msp3, during Anaplasma marginale persistence in vivo. Infect. Immun. 71:6627-6632.
8. Brown, W. C., et al. 2001. Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses. J. Immunol. 166:1114-1124.
9. Brown, W. C., et al. 2004. CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in Msp3. Infect. Immun. 72:3688-3692.
10. Brown, W. C., G. H. Palmer, H. A. Lewin, and T. C. McGuire. 2001. CD4+ T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of Msp1a and Msp1b, preferentially recognize the Msp1a carboxyl terminus that is conserved among strains. Infect. Immun. 69:6853-6862.
11. Brown, W. C., et al. 1998. CD4+ T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66:5406-5413.
12. Dark, M., et al. 2009. Conservation in the face of diversity: multistrain analysis of an intracellular bacterium. BMC Genomics 10:16.
13. Dennis, R., P. O'Hara, M. Young, and K. Dorris. 1970. Neonatal immunohemolytic anemia and icterus of calves. J. Am. Vet. Med. Assoc. 156:1861-1869.
14. Eberhardt, C., et al. 2009. Proteomic analysis of the bacterial pathogen Bartonella henselae and identification of immunogenic proteins for serodiagnosis. Proteomics 9:1967-1981.
15. French, D. M., W. C. Brown, and G. H. Palmer. 1999. Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect. Immun. 67:5834-5840.
16. French, D. M., T. F. McElwain, T. C. McGuire, and G. H. Palmer. 1998. Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemia. Infect. Immun. 66:1200-1207.
17. Futse, J. E., K. A. Brayton, D. P. Knowles, and G. H. Palmer. 2005. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants. Mol. Microbiol. 57:212-221.
18. Futse, J. E., K. A. Brayton, S. D. Nydam, and G. H. Palmer. 2009. Generation of antigenic variants via gene conversion: evidence for recombination fitness selection at the locus level in Anaplasma marginale. Infect. Immun. 77:3181-3187.
19. Futse, J. E., K. A. Brayton, M. J. Dark, D. P. Knowles, and G. H. Palmer. 2008. Superinfection as a driver of genomic diversification in antigenically variant pathogens. Proc. Natl. Acad. Sci. U. S. A. 105:2123-2127.
20. Galletti, M. F., M. W. Ueti, D. P. Knowles, K. A. Brayton, and G. H. Palmer. 2009. Independence of Anaplasma marginale strains with high and low transmission efficiencies in the tick vector following simultaneous acquisition by feeding on a superinfected mammalian reservoir host. Infect. Immun. 77: 1459-1464.
21. Herndon, D. R., G. H. Palmer, V. Shkap, D. P. Knowles, and K. A. Brayton. 2010. Complete genome sequence of Anaplasma marginale subsp. centrale. J. Bacteriol. 192:379-380.
22. Krigel, Y., E. Pipano, and V. Shkap. 1992. Duration of carrier state following vaccination with live Anaplasma centrale. Trop. Anim. Health Prod. 24:209-210.
23. Lopez, J. E., et al. 2005. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect. Immun. 73:8109-8118.
24. Lopez, J. E., et al. 2007. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect. Immun. 75:2333-2342.
25. Macmillan, H., J. Norimine, K. A. Brayton, G. H. Palmer, and W. C. Brown. 2008. Physical linkage of naturally complexed bacterial outer membrane proteins enhances immunogenicity. Infect. Immun. 76:1223-1229.
26. Meeus, P. F. M., K. A. Brayton, G. H. Palmer, and A. F. Barbet. 2003. Conservation of a gene conversion mechanism in two distantly related paralogues of Anaplasma marginale. Mol. Microbiol. 47:633-643.
27. Molad, T., K. A. Brayton, G. H. Palmer, S. Michaeli, and V. Shkap. 2004. Molecular conservation of MSP4 and MSP5 in Anaplasma marginale and A. centrale vaccine strain. Vet. Microbiol. 100:55-64. (Pubitemid 38595599)
28. Noh, S. M., et al. 2006. Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins. Infect. Immun. 74:3471-3479.
29. Noh, S. M., et al. 2008. Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect. Immun. 76:2219-2226.
30. Palmer, G. H., A. F. Barbet, K. L. Kuttler, and T. C. McGuire. 1986. Detection of an Anaplasma marginale common surface protein present in all stages of infection. J. Clin. Microbiol. 23:1078-1083.
31. Palmer, G. H., F. R. Rurangirwa, K. M. Kocan, and W. C. Brown. 1999. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today 15:281-286.
32. Palmer, G. 2009. Sir Arnold Theiler and the discovery of anaplasmosis: a centennial perspective. Ondersteport J. Vet. Res. 76:75-79.
33. Palmer, G., and T. McGuire. 1984. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle. J. Immunol. 133:1010-1015.
34. Palmer, G. H., W. C. Brown, and F. R. Rurangirwa. 2000. Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale. Microbes Infect. 2:167-176.
35. Rodriguez, J., G. H. Palmer, J. Knowles, and K. A. Brayton. 2005. Distinctly different msp2 pseudogene repertoires in Anaplasma marginale strains that are capable of superinfection. Gene 361:127-132.
36. Rogers, R. J., C. K. Dimmock, A. J. De Vos, and B. J. Rodwell. 1988. Bovine leucosis virus contamination of a vaccine produced in vivo against bovine babesiosis and anaplasmosis. Aust. J. Vet. Res. 65:285-287.
37. Seo, G., C. Cheng, J. Tomich, and R. R. Ganta. 2008. Total, membrane, and immunogenic proteomes of macrophage- and tick cell-derived Ehrlichia chaffeensis evaluated by liquid chromatography-tandem mass spectrometry and MALDI-TOF methods. Infect. Immun. 76:4823-4832.
38. Shkap, V., T. Molad, K. A. Brayton, W. C. Brown, and G. H. Palmer. 2002. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates. Infect. Immun. 70:642-648.
39. Theiler, A. 1910. Report of the government veterinary bacteriologist, 1908-1909, p. 7-64. Department of Agriculture, Union of South Africa, Johannesburg, South Africa.
40. Theiler, A. 1912. Gallsickness of imported cattle and the protective inoculation against this disease. Agric. J. Union South Africa 3:7-46.
41. Turton, J., et al. 1998. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe. Ondersteport J. Vet. Res. 65:81-86.
42. van Eijk, M., J. Stewart-Haynes, and H. Lewin. 1992. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 23:483-496.
43. Wilson, A., R. Parker, and K. Trueman. 1980. Experimental immunization of calves against Anaplasma marginale infection: observations on the use of living A. centrale and A. marginale. Vet. Parasitol. 7:305-311.
44. Zhuang, Y., J. E. Futse, W. C. Brown, K. A. Brayton, and G. H. Palmer. 2007. Maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection. Infect. Immun. 75:5185-5190.